Informationen:
Fehler:
ID
14477
Beschreibung
P-glycoprotein Function in Brain Diseases; ODM derived from: https://clinicaltrials.gov/show/NCT00677885
Link
https://clinicaltrials.gov/show/NCT00677885
Stichworte
Versionen (1)
- 17.04.16 17.04.16 -
Hochgeladen am
17. April 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Alzheimer Disease NCT00677885
Eligibility Alzheimer Disease NCT00677885
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Alzheimer Disease NCT00677885
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
alzheimer disease; parkinson disease; frontotemporal dementia
Item
patients with the diagnosis of probable alzheimer disease, parkinson disease, or frontotemporal dementia. all patients must either meet capacity criteria to consent to research, or be able to assign a surrogate decision-maker who is able to consent to research on the subject s behalf.
boolean
C0002395 (UMLS CUI [1])
C0030567 (UMLS CUI [2])
C0338451 (UMLS CUI [3])
C0030567 (UMLS CUI [2])
C0338451 (UMLS CUI [3])
healthy volunteers
Item
healthy volunteers.
boolean
C1708335 (UMLS CUI [1])
psychiatric disease; substance abuse disorder; systemic disease; physical exam
Item
current psychiatric disease, substance abuse or severe systemic disease based on history and physical exam.
boolean
C0004936 (UMLS CUI [1])
C0038586 (UMLS CUI [2])
C0442893 (UMLS CUI [3])
C0031809 (UMLS CUI [4])
C0038586 (UMLS CUI [2])
C0442893 (UMLS CUI [3])
C0031809 (UMLS CUI [4])
laboratory test
Item
laboratory tests with clinically significant abnormalities.
boolean
C0022885 (UMLS CUI [1])
anticoagulants; coagulation disorders; PT and PTT tests
Item
subjects on blood-thinning medications, having coagulation disorders, or clinically significant abnormal blood clotting test (pt/ptt).
boolean
C0003280 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
C2143037 (UMLS CUI [3])
C0005779 (UMLS CUI [2])
C2143037 (UMLS CUI [3])
Study Subject Participation Status
Item
prior participation in other research protocols or clinical care in the last year such that radiation exposure, including that from this protocol, would exceed the guidelines set by the radiation safety committee (rsc).
boolean
C2348568 (UMLS CUI [1])
pregnancy; lactating
Item
pregnancy or breast feeding.
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])
Illicit Drug Testing
Item
positive result on urine screen for illicit drugs.
boolean
C0020896 (UMLS CUI [1])
ability
Item
subjects who cannot lie on their back for extended periods of time.
boolean
C0085732 (UMLS CUI [1])
neurological disease; parkinson disease; frontotemporal dementia
Item
history of neurological disease other than alzheimer disease, parkinson disease, or frontotemporal dementia.
boolean
C0027765 (UMLS CUI [1])
C0030567 (UMLS CUI [2])
C0338451 (UMLS CUI [3])
C0030567 (UMLS CUI [2])
C0338451 (UMLS CUI [3])
cardiac pacemaker
Item
subjects who have a cardiac pacemaker or metal in their body.
boolean
C0030163 (UMLS CUI [1])
cyclosporine a
Item
subjects taking cyclosporine a.
boolean
C0010592 (UMLS CUI [1])